Similar Items: Improved treatment outcomes with bedaquiline when substituted for second-line injectable agents in multidrug-resistant tuberculosis: A retrospective cohort study
- An analysis of the upstream supply chain for second-line drugs for multidrug-resistant tuberculosis
- A pharmacometric approach to optimal use of second line drugs for multidrug-resistant tuberculosis
- Sodium, potassium adenosine triphosphatase as a potential target of the anti-tuberculosis agents, clofazimine and bedaquiline
- Transmission of bedaquiline-resistant tuberculosis in the Western Cape Province, South Africa
- Epidemiological impact of HIV on second - line drug resistance in patients with multidrug resistant tuberculosis in high HIV prevalent settings in South Africa
- Ausceptibility testing and resistance mechanisms to second-line agents against Mycobacterium tuberculosis in Pretoria, South Africa
Author: Meintjes, Graeme
- The immunomodulatory role of prednisone in patients with HIV-associated tuberculosis and assessment of its impact on lung function outcome
- Investigating the molecular pathogenesis of tuberculosis-associated immune reconstitution inflammatory syndrome
- Optimising linezolid use for drug-resistant tuberculosis: pharmacokinetics, toxicity, and resistance
- Characterization of and risk factors for HIV-1 resistance mutations following first line antiretroviral failure in the southern African private sector
- Improved treatment outcomes with bedaquiline when substituted for second-line injectable agents in multidrug-resistant tuberculosis: A retrospective cohort study
- Diagnosis, treatment and immunopathogenesis of the HIV-associated tuberculosis immune reconstitution inflammatory syndrome